1. Home
  2. MEHA vs AZTR Comparison

MEHA vs AZTR Comparison

Compare MEHA & AZTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MEHA

Functional Brands Inc.

N/A

Current Price

$0.19

Market Cap

3.3M

Sector

Health Care

ML Signal

N/A

Logo Azitra Inc

AZTR

Azitra Inc

HOLD

Current Price

$0.24

Market Cap

3.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MEHA
AZTR
Founded
2020
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3M
3.1M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
MEHA
AZTR
Price
$0.19
$0.24
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
852.3K
1.5M
Earning Date
05-29-2026
02-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,797,059.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
5.57
N/A
52 Week Low
$0.18
$0.22
52 Week High
$8.00
$3.92

Technical Indicators

Market Signals
Indicator
MEHA
AZTR
Relative Strength Index (RSI) 34.16 34.21
Support Level $0.18 $0.22
Resistance Level $0.22 $0.29
Average True Range (ATR) 0.02 0.03
MACD 0.00 -0.00
Stochastic Oscillator 14.04 7.91

Price Performance

Historical Comparison
MEHA
AZTR

About MEHA Functional Brands Inc.

Functional Brands Inc operates in the nutraceutical supplement industry. It is a manufacturer and distributor of supplements in categories such as pain, energy, prenatal, general health, bone and joint, gastro, immunity, cardiac, detox, brain and memory, sleep, prenatal and urinary. It is focus on end-consumers through different channels that include pharmacies, wholesalers, international distributors and direct-to-consumers sales. The Company has two reportable segments: 1) Kirkman, which sells a range of nutraceuticals, supplements and related products direct to consumers; 2) HT Naturals, which sells a range of hemp products; and 3) Corporate, which generates no revenue. Key revenue is generated from Kirkman.

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.

Share on Social Networks: